{
    "clinical_study": {
        "@rank": "74120", 
        "brief_summary": {
            "textblock": "RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet\n      known which regimen of radiation therapy is more effective for prostate cancer.\n\n      PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of\n      radiation therapy in treating patients who have localized prostate cancer."
        }, 
        "brief_title": "Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer", 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Compare the 5-year survival rate, in terms of clinical and biological\n      remission, in patients with localized prostate cancer treated with two different\n      radiotherapy regimens using different doses and number of fractions. II. Compare the nadir\n      of PSA and the delay in obtaining the nadir in patients treated with these two regimens.\n      III. Compare acute and long-term toxicity of these two regimens in these patients. IV.\n      Compare overall survival and quality of life in patients treated with these two regimens.\n\n      OUTLINE: This is a randomized, multicenter study. Patients are stratified according to\n      participating center. Patients are randomized to 1 of 2 treatment arms. Arm I: Patients\n      receive radiotherapy to the seminal vesicles at 46 Gy in 23 fractions and to the prostate at\n      70 Gy in 35 fractions, with 5 fractions per week. Arm II: Patients receive radiotherapy to\n      the seminal vesicles as in arm I and to the prostate at 80 Gy in 40 fractions, with 5\n      fractions per week. Treatment continues in both arms in the absence of disease progression\n      or unacceptable toxicity. Quality of life is assessed annually. Patients are followed every\n      4 months for a minimum of 5 years.\n\n      PROJECTED ACCRUAL: A total of 306 patients (153 per arm) will be accrued for this study\n      within 2.5 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Localized prostate cancer: T2a-T3a OR T1b or T1c with PSA at\n        least 10 ng/mL OR T1b or T1c with Gleason score 7-10 No T3b or T4; positive biopsy of\n        nodal excision N0, or any N with bilateral removal and the estimated risk of nodal\n        invasion is at least 10% M0 (by bone scintograph and chest x-ray) PSA less than 50 ng/mL\n\n        PATIENT CHARACTERISTICS: Age: Under 75 Performance status: WHO 0-1 Life expectancy: At\n        least 10 years Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified\n        Other: No other prior invasive malignancy within the past 5 years except basal cell\n        carcinoma No social, familial, or geographic obstacles that would preclude study\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: No prior biologic therapy No concurrent\n        biologic therapy Chemotherapy: No prior chemotherapy No concurrent chemotherapy Endocrine\n        therapy: No prior hormonal therapy including adjuvant therapy No concurrent hormonal\n        therapy Radiotherapy: No prior pelvic radiotherapy Surgery: No prior radical anterior\n        prostatectomy for cancer No prior castration"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "74 Years", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "February 2, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00010244", 
            "org_study_id": "CDR0000068458", 
            "secondary_id": [
                "FRE-FNCLCC-PAC-GETUG-06-99001", 
                "EU-20037"
            ]
        }, 
        "intervention": {
            "intervention_name": "radiation therapy", 
            "intervention_type": "Radiation"
        }, 
        "keyword": [
            "stage IIB prostate cancer", 
            "stage IIA prostate cancer", 
            "stage III prostate cancer"
        ], 
        "lastchanged_date": "February 18, 2011", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/FRE-FNCLCC-PAC-GETUG-06-99001"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33075"
                    }, 
                    "name": "Hopital Saint Andre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21079"
                    }, 
                    "name": "Centre de Lute Contre le Cancer,Georges-Francois Leclerc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69373"
                    }, 
                    "name": "Centre Leon Berard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13273"
                    }, 
                    "name": "Institut J. Paoli and I. Calmettes"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Metz", 
                        "country": "France", 
                        "zip": "55038"
                    }, 
                    "name": "Hopital Notre-Dame de Bon Secours"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34298"
                    }, 
                    "name": "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes-Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "CRLCC Nantes - Atlantique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06189"
                    }, 
                    "name": "Centre Antoine Lacassagne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75651"
                    }, 
                    "name": "CHU Pitie-Salpetriere"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75248"
                    }, 
                    "name": "Institut Curie - Section Medicale"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pierre Benite", 
                        "country": "France", 
                        "zip": "69495"
                    }, 
                    "name": "Hopital Jules Courmont - Centre Hospitalier Lyon Sud"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France", 
                        "zip": "86021"
                    }, 
                    "name": "Hopital Jean Bernard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51056"
                    }, 
                    "name": "Institut Jean Godinot"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35064"
                    }, 
                    "name": "Centre Eugene Marquis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76038"
                    }, 
                    "name": "Centre Henri Becquerel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31052"
                    }, 
                    "name": "Institut Claudius Regaud"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37044"
                    }, 
                    "name": "Centre Hospitalier Universitaire Bretonneau de Tours"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vandoeuvre-les-Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "Centre Alexis Vautrin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "official_title": "Conformational, Curative Ratiotherapy For Prostate Cancer (NO, N-): Phase III Multicenter Study Of The Contribution To Survival Without Clinical Or Biological Change With A Dose Variation Of 15% (80 Gy VS 70 Gy)", 
        "overall_official": {
            "affiliation": "Centre Alexis Vautrin", 
            "last_name": "P. Bey, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00010244"
        }, 
        "results_reference": {
            "PMID": "21147514", 
            "citation": "Beckendorf V, Guerif S, Le Pris\u00e9 E, Cosset JM, Bougnoux A, Chauvet B, Salem N, Chapet O, Bourdain S, Bachaud JM, Maingon P, Hannoun-Levi JM, Malissard L, Simon JM, Pommier P, Hay M, Dubray B, Lagrange JL, Luporsi E, Bey P. 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial. Int J Radiat Oncol Biol Phys. 2010 Dec 11; [Epub ahead of print]"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNICANCER", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 1999", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2011"
    }, 
    "geocoordinates": {
        "CHU Pitie-Salpetriere": "48.857 2.352", 
        "CRLCC Nantes - Atlantique": "47.21 -1.602", 
        "Centre Alexis Vautrin": "48.661 6.174", 
        "Centre Antoine Lacassagne": "43.696 7.266", 
        "Centre Eugene Marquis": "48.113 -1.676", 
        "Centre Henri Becquerel": "49.443 1.1", 
        "Centre Hospitalier Universitaire Bretonneau de Tours": "47.394 0.685", 
        "Centre Leon Berard": "45.764 4.836", 
        "Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle": "43.611 3.877", 
        "Centre de Lute Contre le Cancer,Georges-Francois Leclerc": "47.322 5.041", 
        "Hopital Jean Bernard": "46.58 0.34", 
        "Hopital Jules Courmont - Centre Hospitalier Lyon Sud": "45.703 4.825", 
        "Hopital Notre-Dame de Bon Secours": "49.12 6.177", 
        "Hopital Saint Andre": "44.838 -0.579", 
        "Institut Claudius Regaud": "43.605 1.444", 
        "Institut Curie - Section Medicale": "48.857 2.352", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Institut J. Paoli and I. Calmettes": "43.296 5.37", 
        "Institut Jean Godinot": "49.258 4.032"
    }
}